What is the recommended melatonin dosing schedule for adults, including starting dose, maximum dose, and adjustments for older adults or patients on interacting medications?

Melatonin Dosing for Adults

For circadian rhythm disorders (delayed sleep-wake phase disorder), use melatonin 5 mg taken 1.5-2 hours before desired bedtime, while for chronic insomnia in older adults (≥55 years), use 2 mg prolonged-release formulation 1-2 hours before bedtime. 1, 2

Context: Different Indications Require Different Approaches

The evidence clearly distinguishes between two primary uses of melatonin with distinct dosing strategies:

For Circadian Rhythm Sleep-Wake Disorders (DSWPD)

Recommended dose: 5 mg, taken 1.5-2 hours (or up to 3 hours) before habitual bedtime

• The American Academy of Sleep Medicine guidelines support using strategically timed melatonin for adults with delayed sleep-wake phase disorder 1
• Studies demonstrating efficacy used 5 mg doses administered between 19:00-21:00 for 28 days 1
• Recent meta-analysis suggests optimal efficacy peaks at 4 mg/day when administered 3 hours before desired bedtime, which is more effective than the commonly used 2 mg given 30 minutes before bed 3
• The timing is critical: administration 1.5-3 hours before bedtime allows melatonin to phase-advance the circadian rhythm effectively

For Chronic Insomnia in Older Adults (≥55 years)

Recommended dose: 2 mg prolonged-release formulation, taken 1-2 hours before bedtime

• Important caveat: The AASM guidelines actually recommend AGAINST using melatonin for chronic insomnia treatment, stating benefits approximately equal harms 2
• However, if used, the evidence base supports 2 mg prolonged-release in adults ≥55 years 2, 4
• This formulation mimics natural melatonin secretion patterns and has demonstrated improvements in sleep quality, latency, and morning alertness in 3-week and 6-month trials 4
• Lower doses (0.5-1 mg) may be preferable to avoid supra-physiological levels 5

Age-Specific Dosing Adjustments

Older Adults (≥55 years)

• Start with 1-2 mg prolonged-release formulation 2, 4
• Older adults have decreased endogenous melatonin production, making them more responsive to lower doses 6, 4
• Higher doses produce more prolonged supra-physiological blood levels in elderly patients compared to younger adults 5
• Use the lowest effective dose to best mimic physiological circadian rhythm 5
• Maximum studied dose: 6 mg, though 2 mg is typically sufficient 7, 4

Younger Adults (18-54 years)

• For circadian disorders: 3-5 mg 7
• Timing remains 1.5-3 hours before desired bedtime 3

Maximum Dose Considerations

• Practical maximum: 5 mg for circadian disorders 1
• Doses up to 4 mg show optimal dose-response effects 3
• Higher doses (>5 mg) do not demonstrate additional benefit and may cause prolonged supra-physiological levels 5
• Studies have used doses up to 50 mg/kg without serious adverse effects, but this is not clinically recommended 5

Drug Interactions and Special Populations

Patients on Interacting Medications

Key interactions to consider:

• Fluvoxamine: Increases melatonin levels significantly; reduce melatonin dose or avoid combination
• CYP1A2 inhibitors (ciprofloxacin, fluvoxamine): May increase melatonin levels
• CYP1A2 inducers (smoking, carbamazepine): May decrease melatonin effectiveness
• Benzodiazepines: Melatonin may facilitate benzodiazepine discontinuation in elderly insomniacs 6
• Anticoagulants: Monitor closely as melatonin may have antiplatelet effects

Patients with Comorbidities

• Depression: 5 mg doses showed efficacy in adults with DSWPD and comorbid depression 1
• Psychiatric conditions: Evidence supports use but with appropriate monitoring
• Hepatic impairment: Start with lower doses due to reduced metabolism

Formulation Matters

• Immediate-release: Better for circadian rhythm disorders and mimicking physiological patterns 5
• Prolonged-release: Preferred for insomnia in older adults (≥55 years) 2, 4
• Fast-release formulations were used in pediatric studies but adult data favor prolonged-release for insomnia 1

Critical Timing Principles

The timing of administration is as important as the dose:

• For phase advancement (DSWPD): 1.5-3 hours before desired bedtime 1, 3
• For insomnia: 1-2 hours before bedtime 2, 4
• Optimal timing based on recent evidence: 3 hours before bedtime (around 6 PM for 9 PM bedtime) maximizes efficacy 3, 8
• Consistent nightly timing is essential for circadian entrainment

Common Pitfalls to Avoid

1. Taking melatonin too close to bedtime (e.g., 30 minutes before): This is less effective than 1.5-3 hour advance timing 3
2. Using excessively high doses: Doses >5 mg don't improve efficacy and may cause prolonged supra-physiological levels 5
3. Wrong formulation for indication: Immediate-release for circadian disorders; prolonged-release for insomnia in elderly 4, 5
4. Expecting immediate results: Treatment duration of 3-4 weeks may be needed 1, 4
5. Using for general insomnia in younger adults: Evidence does not support this; AASM recommends against it 2

Safety Profile

• Well-tolerated with tolerability similar to placebo in clinical trials 4
• No dependence, tolerance, rebound insomnia, or withdrawal symptoms reported 4
• Mild side effects when using usual doses 7
• No impairment of psychomotor functions, memory, or driving skills the next morning 4
• Long-term safety data (up to 6 months) support continued use when indicated 4

Duration of Treatment

• Circadian disorders: Minimum 6 nights, typically 28 days for full effect 1
• Insomnia in elderly: Up to 13 weeks approved in EU; studies support up to 6 months 4
• Reassess efficacy after 3-4 weeks of consistent use